SEC Form 4 · accession 0001493152-16-015200

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CFO and EVP

Period of report

Nov 15, 2016

Accepted (ET)

Nov 16, 2016 · 8:48 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000748592

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 15, 2016	A	500	$7.46	A	28,210	D
Common Stock^F1	Nov 15, 2016	A	250	$7.47	A	2,100	I	See Footnote
Common Stock^F2	Nov 15, 2016	A	250	$7.47	A	2,100	I	See Footnote

No Table II lines on this filing.